We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Veterinary Diagnostics Revenue Increasing Faster Than Overall IVD

By LabMedica International staff writers
Posted on 06 Jan 2014
Print article
Veterinary diagnostics, at nearly USD 2 billion dollars, represent a supplementary but increasingly attractive course of market development for companies active in the USD 55 billion in vitro diagnostics (IVD) sector.

The findings were published in a new report by Kalorama Information (New York, NY, USA). Analyst Emil Salazar, explained that companies entering the veterinary diagnostics market benefit from lower regulatory demands, ready applications of medical diagnostic product platforms, and generally greater opportunities for revenue growth.

According to Emil Salazar, the past year visited the US IVD market with rigid cuts in lab test reimbursements and a regulatory rollout of the Affordable Care Act (ACA) that did little to instill industry confidence. Cost drivers in medical spending were able to only in part offset such market disturbances, and generate national IVD market growth of around 3%. Quietly outperforming its larger sister market, the US veterinary diagnostics market grew by about 5% in 2013.

Metrics refer to a company's Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA). A metric can be used to show a company's profitability, but not its cash flow, EBITDA, earnings per share, or any other financial measures. Several metrics support the projection of veterinary diagnostics market growth: veterinary lab testing service revenue, rapid assay sales, and veterinary lab requisition volumes under leaders IDEXX (Westbrook, MN, USA) and VCA Antech (Los Angeles, CA, USA). Trends in these metrics reflect the base conditions in demand for veterinary testing by also excluding companies’ sales or placements of capital instrumentation at veterinary practices.

The fundaments of the veterinary diagnostics market in the United States were tested by a severe decline in consumer spending on pets during the economic recession. Typically a growth sector, veterinary practices were challenged for growth between 2009 and 2011. Subsequent recovery in the economy and consumer confidence reversed the fortunes of the veterinary care industry, and saw renewed, consistent growth in the veterinary diagnostics market.

The US market for pet care products and veterinary services is dependent upon a customer base of upper middle-income to affluent pet owners. "The recovery of the veterinary services market in recent years was aided in large part by the increasing role of higher income households, who are also more likely to pay for consistent and new vet lab testing," explained Emil Salazar. While veterinary office visits may rise only slightly (or even fall) in some years, test costs are increasing substantially with greater product complexity and growing reliance on IVD products during episodes of veterinary care.

"Future veterinary diagnostics market growth will depend upon the development of markets for more sophisticated products such as molecular diagnostic tests and increasing testing intensity as instrument placements decline in saturated markets," Emil Salazar said.

Kalorama Information’s report, The World Market for Veterinary Diagnostics, provides more information including breakouts for various segments of veterinary diagnostics, and discussions of trends in the industry. Profiles of key competitors are also included.

Related Links:

Kalorama Information
IDEXX
VCA Antech


New
Gold Member
Pneumocystis Jirovecii Detection Kit
Pneumocystis Jirovecii Real Time RT-PCR Kit
Antipsychotic TDM AssaysSaladax Antipsychotic Assays
New
Malaria Rapid Test
OnSite Malaria Pf/Pan Ag Rapid Test
New
Newborn Screening Test
NeoMass AAAC 3.0

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The smartphone technology measures blood hemoglobin levels from a digital photo of the inner eyelid (Photo courtesy of Purdue University)

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

Blood hemoglobin tests are among the most frequently conducted blood tests, as hemoglobin levels can provide vital insights into various health conditions. However, traditional tests are often underutilized... Read more

Immunology

view channel
Image: Under a microscope, DNA repair is visible as bright green spots (“foci”) in the blue-stained cell DNA. Orange highlights actively growing cancer cells (Photo courtesy of WEHI)

Simple Blood Test Could Detect Drug Resistance in Ovarian Cancer Patients

Every year, hundreds of thousands of women across the world are diagnosed with ovarian and breast cancer. PARP inhibitors (PARPi) therapy has been a major advancement in treating these cancers, particularly... Read more

Microbiology

view channel
Image: HNL Dimer can be a novel and potentially useful clinical tool in antibiotic stewardship in sepsis (Photo courtesy of Shutterstock)

Unique Blood Biomarker Shown to Effectively Monitor Sepsis Treatment

Sepsis remains a growing problem across the world, linked to high rates of mortality and morbidity. Timely and accurate diagnosis, along with effective supportive therapy, is essential in reducing sepsis-related... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.